MIREVEN
MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy.
MIREVEN
Industry:
Biotechnology Therapeutics
Founded:
2010-01-01
Website Url:
http://www.mireven.com.au
Total Employee:
1+
Status:
Active
Contact:
61 3 9657 0700
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Cytovant
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.
SiNOPSEE Therapeutics
SiNOPSEE THERAPEUTICS Pvt Ltd is a bio-pharmaceutical company focused on the discovery, design.
Current Advisors List
Official Site Inspections
http://www.mireven.com.au
- Host name: 199.16.173.59
- IP address: 199.16.173.59
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MiReven"
Mireven | mRx-7: A new weapon for cancer | Home
MiReven is a biopharmaceutical company focused on developing mRx-7 as a new cancer therapy. The world of RNA-based therapeutics is an entirely new clinical treatment. mRx-7 is a …See details»
About Us - Mireven
MiReven Pty Ltd is an Australian-based biotechnology company specialising in the design, development and commercialisation of synthetic mimics of microRNA-7 (miR-7) for the …See details»
Management and Scientists - Mireven
Andy has deep understanding and awareness of RNA therapeutics and cancer biology, which is of particular relevance to miReven. Andy is an inventor on more than 15 patent families. Andy’s experience also extends to fundraising efforts …See details»
miReven Pty Ltd - LinkedIn
MiReven Pty Ltd | 61 followers on LinkedIn. miR-7: An anti-cancer micro RNA miReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company …See details»
MiReven Company Profile | Management and Employees List
MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company was formed in 2010 through an investment from the Medical Research …See details»
MiReven - Crunchbase Company Profile & Funding
MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy.See details»
Mireven Receives Further $500K From MRCF - BioSpace
Aug 27, 2012 · MiReven recently signed two international R&D collaborations to investigate the therapeutic efficacy of systemically delivered miR-7 in several different cancer models, thereby …See details»
miReven Pty Ltd: Contact Details and Business Profile
MiReven Pty Ltd is a Biotechnology, Pharmaceutical Manufacturing, and Pharmaceuticals company_reader located in Nedlands, Western Australia with $5 million in revenue and 3 …See details»
Investors & Stakeholders - Mireven
Through our clinical trials facility, Linear Clinical Research Ltd, we work with medical innovators from around the world to test and optimise pioneering treatments and drugs – innovations with …See details»
MiReven - Company Profile - Tracxn
Oct 20, 2024 · MiReven - Company developing cancer therapies through mechanisms that involve EGRF. Founded by Keith Giles and Peter Leedman in the year 2010. MiReven has …See details»
Mireven - Techboard
Jun 29, 2015 · MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company was formed in 2010 through an investment from the Medical …See details»
MiReven Pty Ltd - VentureRadar
Website: http://mireven.com.au/ MiReven is a biopharmaceutical company focused on developing miR-7 as a cancer therapy. The Company was formed in 2010 through an investment from the …See details»
MiReven - Overview, News & Similar companies | ZoomInfo.com
View MiReven (www.mireven.com.au) location in Western Australia, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Research programme: microRNA 7-based therapeutics - MiReven
Research programme: microRNA 7-based therapeutics - MiReven Alternative Names: miR-7 cancer therapeutics - MiReven Pty; miR-7 mimetics - MiReven/Silence Therapeutics; miR-7-5p …See details»
miReven - Mireven
MiReven is a biopharmaceutical company focused on developing mRx-7 as a new cancer therapy.See details»
Mireven Genetics & Genomics News | GenomeWeb
As it awaits the publication of in vitro data from its lead cancer program, Australian microRNA drugs startup MirEven has moved into proof-of-concept animal studies to test various oligo …See details»
MiReven - Business News
MiReven. Special Reports. Biotech sector haunted by 'valley of death' By Shanna Crispin. FEATURE: The state’s biotechnology sector is heating up as investors look for the next wave …See details»
Our Science - Mireven
MicroRNAs have emerged as an important class of small RNAs encoded in the genome. They act as master regulators to control the expression of sets of genes and entire cellular pathways. …See details»
miReven - Products, Competitors, Financials, Employees, …
MiReven is a biopharmaceutical company focused on developing RNA-based therapeutics for cancer treatment. Use the CB Insights Platform to explore miReven's full profile.See details»
Development of a new weapon for cancer | Australia - Mireven
MiReven is commercialising the pioneering work of Prof Peter Leedman and Dr Keith Giles at the Harry Perkins Institute for Medical Research on the anti-cancer potential of miR-7.See details»